Target intelligence / Profile preview

Ubiquitin-specific-processing protease 7 mRNA (USP7 mRNA)

Target
USP7 mRNA
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Ubiquitin-specific-processing protease 7 (USP7) mRNA is the messenger RNA transcript that encodes the USP7 protein, a prominent member of the deubiquitinating enzyme family (UniProt: Q93009). USP7, also known as HAUSP, plays a pivotal role in maintaining cellular homeostasis by regulating the stability of various proteins, most notably the tumor suppressor p53 and its E3 ligase MDM2 (NCBI Gene: 7156). In many human cancers, USP7 is overexpressed, which leads to the degradation of p53 and facilitates oncogenesis and therapeutic resistance (Pfoh et al., 2015; PubMed: 26138443). Consequently, USP7 mRNA has emerged as a strategic therapeutic target for knockdown approaches using antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs) to restore p53 function and induce apoptosis in malignant cells. Beyond oncology, USP7 is involved in DNA damage repair, epigenetic regulation, and immune signaling, and its genetic alterations are linked to the neurodevelopmental condition Hao-Fountain syndrome (Hao et al., 2015; PubMed: 25865494). Targeting the mRNA transcript offers a method to bypass the challenges associated with developing highly selective small-molecule inhibitors for the USP7 catalytic site.

Other names
HAUSP mRNAHerpesvirus-associated ubiquitin-specific protease mRNAUSP7 transcriptUbiquitin carboxyl-terminal hydrolase 7 mRNA
02

Mechanism of action

Targeting USP7 mRNA typically involves RNA interference (RNAi) or antisense-mediated degradation (e.g., RNase H-mediated cleavage), which prevents the translation of the USP7 protein and subsequently modulates the stability of its substrates like p53 and MDM2 (Vriend et al., 2016; PubMed: 27105553).

03

Biological functions

Protein translationRegulation of protein stabilityDNA damage responseCell cycle regulationApoptosis regulationEpigenetic regulation
04

Disease associations

CancerHao-Fountain syndromeNeurodevelopmental disordersViral infectionImmune evasion
05

Safety considerations

Off-target hybridization effectsInduction of innate immune responses to nucleic acidsDelivery challenges to specific tissuesPotential systemic toxicity from p53 over-activation
06

Interacting drugs

USP7-specific small interfering RNA (siRNA)

1 more in the full profile.

07

Biomarkers

USP7 mRNA expression levelsUSP7 protein levelsp53 protein stabilityMDM2 protein levels

Beyond the preview

Go deeper on Ubiquitin-specific-processing protease 7 mRNA (USP7 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-specific-processing protease 7 mRNA (USP7 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call